Alterola Biotech, Inc. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported net loss was USD 1.74 million compared to USD 6.47 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0033 USD | -10.81% | -10.81% | -8.33% |
1st Jan change | Capi. | |
---|---|---|
-8.33% | 4.56M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.15% | 22.25B | |
-13.14% | 22.09B | |
-7.73% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ABTI Stock
- News Alterola Biotech, Inc.
- Alterola Biotech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023